Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?

• Autori principali: Chatzimichail E (Autore), Pfau K (Autore), Gatzioufas Z (Autore), Panos GD (Autore)
• Natura: Libro
• Pubblicazione: Dove Medical Press, 2024-02-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Eleftherios Chatzimichail,1 Kristina Pfau,1,2 Zisis Gatzioufas,1 Georgios D Panos3,4 1Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland; 2Department of Ophthalmology, University Hospital Bonn, Bonn, Germany; 3Department of Ophthalmology, Queen's Medical Centre, Notti...